. 2018 Apr 23;9:798. doi: 10.3389/fimmu.2018.00798

Table 2.

Overview of the experiments and methods employed.

Experiment	Experimental group	Treatment	No. of mice	Survival assessed	BL assessed	No. of slides for histometry	Serum samples for Luminex and ELISA
1	Positive control	–	12	Yes	No	12	No
1	AAS	LDA	12	Yes	No	11	No

2	Positive control	–	24	No	Yes	18	Yes
2	AAS	LDA	24	No	Yes	13	Yes

3	Positive control	–	12	Yes	No	12	No
3	AAS	LDA	12			12	No

4	sham	sham	12			12	No
	BCG	BCG	12			12	No
	BCG + AAS	BCG + LDA	12			12	No

5	Rimstar	Rimstar	12	Yes	No	12	No
5	Rimstar + AAS	Rimstar + LDA	12	Yes	No	12	No

Negative ct	Negative ct	–	6	No	No	No	Yes, only Luminex

AAS, aspirin; LDA, low-dose aspirin 3 mg/kg/day; BCG, bacille Calmette–Guerin vaccine; RIMSTAR, rifampicin 150 mg + isoniazid 75 mg + pyrazinamid 400 mg + ethambutol 275 mg, adjusted to mouse weight; Negative ct, negative control, healthy animals.